Company / Current Assets
Axsome Therapeutics, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$589.0M
FY2025
5-year range
$86.5M / $589.0M
FY2021-FY2025
Trend
+21.4%
vs FY2024
Sector context
#100 of 213
Health Care
What the data says
At $589M, Axsome Therapeutics, Inc.'s current assets ranks #100 of 213 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $15M in FY2018 to $589M in FY2025.
Based on SEC 10-K filings.
$589M in FY2025 with a 5-year CAGR of +26.2%.
Improved from $504M to $589M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +33.8%
- 5-Year CAGR
- +26.2%
- 10-Year CAGR
- -
Sector benchmark
#100 of 213 in Health CareTop 47% of 213This company $589.0M Sector average $2.5B
▼
-76.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +26.2%, indicating consistent growth.
- In FY2025, current assets increased 21.4% year-over-year.
- Ranks #100 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $589.0M | +21.4% |
| FY2024 | $485.1M | -3.8% |
| FY2023 | $504.3M | +105.3% |
| FY2022 | $245.6M | +183.9% |
| FY2021 | $86.5M | -53.0% |
| FY2020 | $184.0M | -16.5% |
| FY2019 | $220.4M | +1348.4% |
| FY2018 | $15.2M | -56.9% |
| FY2017 | $35.3M | -7.1% |
| FY2016 | $38.0M | -22.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026